Revolution™ EVO Gen 2

Defying time

Revolution™ EVO Gen 2 defies time by helping you surpass your day-to-day challenges at every step of the care cycle

Paving the way to the future

Revolution™ EVO Gen 2 defies time by helping you surpass your day-to-day challenges at every step of the care cycle

OVERVIEW NATIVE TECHNOLOGIES INTELLIGENT SOLUTIONS CLINICAL IMAGE GALLERY

Clarity Imaging Chain

To enhance spatial resolution

The Clarity Imaging Chain was completely redesigned for Revolution EVO Gen 2 to deliver high spatial resolution, so you can clearly see details as small as 0.28 mm.

The Clarity Imaging Chain features:

  • The Performix 40 Plus tube with its stable dual focal spot for better precision and its 0.35-second routine rotation speed for faster scan times.
  • Highlight Clarity detector inherited from the breakthrough technology introduced on Revolution CT.

ASiR-V*

To make low dose routine or improve imaging quality

ASiR-V* is our novel iterative reconstruction technology. It has been designed to reduce noise levels, improve low-contrast detectability and reduce dose in routine imaging.1

Smart Flow Technologies with Xtream Display

Help you improve productivity

Designed to help you improve productivity by streamlining your workflow and access to information, Smart Flow technologies enable fast, hands-free patient positioning, exam prescription from the patient’s side, integrated injections, real-time reconstruction up to 55 images during the scan with Image Check and access to advanced applications right on the console. With the IQ Enhance pitch booster, you can scan a chest in as fast as two seconds with 175 mm per second acquisition speed to help shorten patient breath-holds while maintaining image quality.

Smart Dose Technology

Revolution EVO Gen 2 features intelligent technology designed to help you acquire high-quality images using lower doses of radiation, contributing to more accurate diagnoses and lower exposures for patients. Dose management tools such as CT 4Kids dose-optimized pediatric reference scan protocols, 3D Dose Modulation, Organ Dose Modulation, Dose Check, DICOM DRSR and more are all at your fingertips. Revolution EVO Gen 2 is also compliant with NEMA XR 25 and XR 29 standards.

Smart Cardiac Technologies

Set up complex cardiac procedures quickly, reliably, and repeatedly, with Smart Cardiac tools are available on the Advantage Workstation*.

SnapShot Assist: Easily complete cardiac exams in as few as five beats with SnapShot Assist, which advises you of the best acquisition technique based on the patient’s heart rate and BMI.  

SnapShot Pulse: Prospective gating with SnapShot Pulse allows for significant dose reduction in coronary imaging as compared to an ECG-gated helical acquisition mode.

SnapShot Freeze2: Reducing motion blurring in vessels by up to a factor of six, SnapShot Freeze facilitates your diagnosis by freezing coronary motion even in higher-heart-rate coronary CT exams. It delivers a 58 msec-equivalent gantry speed with an effective temporal resolution of 29 msec3.

Dual-energy Imaging

Dual-energy imaging allows easy configuration of back-to-back axial or helical scans of the same anatomy at two different X-ray energies (kVs). 

The dual-energy data can be quickly post-processed right on the console or on the Advantage Workstation with easy image registration and one-click ROI ratio for simple analysis.

ASiR-V*

ASiR-V* focuses primarily on more advanced noise and object modeling than ASiR with added physics modeling to help reduce noise, improve low-contrast detectability, and reduce artifacts.

  • Routinely image with up to 82% less dose1. Combining the speed of ASiR with added capabilities from Veo full model-based iterative reconstruction, the novel ASiR-V* iterative reconstruction algorithm brings low dose and improved quality to routine imaging.
  • Up to 100% better spatial resolution1. ASiR-V* has the capability to improve spatial resolution compared to FBP by allowing the reconstruction of higher-resolution images with no increase in image noise.
  • Up to 135% improved low-contrast detectability1. ASiR-V* improves the detectability of low-contrast objects by up to 135% when compared to corresponding FBP reconstructions at the same dose.
  • Up to 91% less image noise1. Depending upon the scan technique and reconstruction parameters, ASiR-V* can significantly reduce electronic image noise compared to FBP at the same dose.
  • Less streak artifact1. ASiR-V* has the capability to reduce low-signal artifact, such as streak artifact, compared to FBP.

Intelligent solutions to help you transform your workflow tangle into a streamlined pathway enabling you to focus on the most important, your patients.

Resources

  • Interactive brochure

    Download
  • Tube Watch brochure

    Download
  • Imaging with Revolution EVO - Advanced Imaging for Private Practices

    Download
  • Imaging with Revolution EVO - Complex Polytrauma Imaging in the ER

    Download
*Optional
1. In clinical practice, the use of ASiR or * may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. For ASiR-V*, Low contrast detectability (LCD), image noise, spatial resolution and artifacts were assessed using reference factory protocols comparing ASiR-V* and FBP. The LCD measured in 0.625 mm slices and tested for both head and body modes using the MITA CT IQ Phantom (CCT183, The Phantom Laboratory), using model observer method.
2. SnapShot Freeze requires CardIQ Xpress 2.0 Reveal on AW or AW Server
3. 20% decrease of mean reading time during a typical working period (07:00am-07:00pm).
4. Some of the technologies herein are technologies in development that represent ongoing research and development efforts. These technologies are not products and may never become products. Not for sale. Some products are not cleared or approved by FDA and/or some other countries for commercial availability.
5. As demonstrated in cardiac phantom testing.